Approved for public listing
5-amino-1MQ 5mg
- Specification
- 5mg
- Purity
- Not published
30 vials in stock
$88.99
Approved for public listingCOA pending
SLU-PP-332 5mg
Also referenced as: slu pp 332 · research · slupp332 · metabolic research
Preclinical ERR-agonist research compound studied for oxidative metabolism, endurance and energy expenditure. This product is supplied in the project catalogue as 5mg. Supplier availability or commercial vial strength should not be interpreted as a clinical dose or evidence of therapeutic efficacy. For laboratory research use only. Not intended for human consumption.
Research categories
Fields of laboratory research only. Not therapeutic claims, indications or evidence of efficacy.
$98.99
20 vials in stock
Bundle pricing — buy more, pay less per vial
Prices in AUD, GST inclusive. Bundle discounts apply per catalogue record.
- Specification
- 5mg
- Form
- Lyophilised powder or solution as supplied
- Purity
- [INFORMATION REQUIRED]
- Purity method
- [INFORMATION REQUIRED]
- Identity method
- [INFORMATION REQUIRED]
- Batch
- [INFORMATION REQUIRED]
- Lot
- [INFORMATION REQUIRED]
- Storage
- [INFORMATION REQUIRED]
- Stock
- In stock
Technical record
Documentation policy
Peptide Research publishes analytical values only where a certificate exists for the lot in question. Where a field reads pending, no verified source document has been supplied — we do not substitute typical or supplier-marketing values.
No human-use information
No dosage, reconstitution-for-administration, protocol or therapeutic-outcome information is published for any record on this site.
Related records
Approved for public listing
5-amino-1MQ 50mg
- Specification
- 50mg
- Purity
- Not published
Not currently held in stock
$123.99